Evidence for Clonally Associated Increasing Rates of Azithromycin Resistant Neisseria gonorrhoeae in Rio de Janeiro, Brazil

• Published in: BioMed research international Vol. 2019; no. 2019; pp. 1 - 6
• Main Authors: Bonelli, Raquel R., Caniné, Maria Cristina A., Francisco Junior, Ronaldo da S., Medeiros, Raphael C., Justo-da-Silva, Livia H., Skaf, Larissa B., Barros dos Santos, Késia T., Fracalanzza, Sergio E. L.
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2019; Hindawi; Hindawi Limited
• Subjects: Antibiotics; Azithromycin; Ceftriaxone; Epidemiology; Females; Laboratories; Minimum inhibitory concentration; Multilocus sequence typing; Mutation; Penicillin; Therapy; Brazil; United States > US; Rio de Janeiro Brazil

Azithromycin is one of the drugs used in the combined therapy for syndromic treatment of gonorrhoea in many countries, including Brazil. Our research group, which receives isolates from clinical laboratories since 2006, has detected, after 2016, a tendency of rising rates of azithromycin resistance,...